rabbit anti human phd2 (Cell Signaling Technology Inc)
Structured Review

Rabbit Anti Human Phd2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 87 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human phd2/product/Cell Signaling Technology Inc
Average 95 stars, based on 87 article reviews
Images
1) Product Images from "Genetic modifications of EGLN1 reactivate HbF production in β 0 -thalassemia/HbE."
Article Title: Genetic modifications of EGLN1 reactivate HbF production in β 0 -thalassemia/HbE.
Journal: Heliyon
doi: 10.1016/j.heliyon.2024.e38020
Figure Legend Snippet: Fig. 1. Targeted sequencing reveals three PHD2 variants in 57 β0-thalassemia/HbE patients. Schematic diagram representing the human EGLN1 gene (58,532 bp; NC_000001.11: 231,363,756–231,422,287) and PHD2 protein (426 aˆa; UniProtKB: Q9GZT9). MYND, MYND zinc finger domain; Catalytic domain, ferrous iron and 2-oxoglutarate (2OG)-dependent HIF prolyl hydroxylase domain. Arrow lines indicate variants identified in this study.
Techniques Used: Sequencing
Figure Legend Snippet: Fig. 2. EGLN1-specific gRNA mediated PHD2 knockdown. (A) Editing efficiency of sgRNAs used in this study. (B) Quantitative real-time PCR demonstrating the relative EGLN1 mRNA expression normalized to the GAPDH mRNA expression at day 14 of culture. (C) Representative western blot analysis showing the expression of PHD2, BCL11A, GATA1 and GAPDH at day 14 of culture. Data are presented as mean ± SD. *, P < 0.05; **, P < 0.005; ****, P < 0.0001.
Techniques Used: Knockdown, Real-time Polymerase Chain Reaction, Expressing, Western Blot
Figure Legend Snippet: Fig. 3. HbF induction after PHD2 manipulations. (A) Quantitative real-time PCR demonstrating the relative HBG mRNA expression normalized to the GAPDH mRNA expression at day 14 of culture. (B) Relative HbF levels compared to the control (sgAAVS1) at day 16 of culture. (C) Repre sentative hemoglobin analysis by HPLC. Data are presented as mean ± SD. *, P < 0.05; **, P < 0.005.
Techniques Used: Real-time Polymerase Chain Reaction, Expressing, Control
Figure Legend Snippet: Fig. 4. Effects of PHD2 manipulations on erythroid maturation. (A) Representative erythroid differentiation analysis by flow cytometry at day 14 of culture. (B) Representative images of β0-thalassemia/HbE erythroid progenitor cells obtained from cytocentrifugation and Wright-Giemsa staining at day 14 of culture. Arrows indicate late-stage erythroid cells.
Techniques Used: Flow Cytometry, Staining

